Skip to content

What is the use of fenofibrate Tablet?

3 min read

Fenofibrate is a fibrate-class medication used primarily to treat hypertriglyceridemia and hypercholesterolemia, conditions affecting millions of adults. This prescription drug works in conjunction with a proper diet and exercise to help regulate high levels of fat-like substances in the blood.

Quick Summary

Fenofibrate tablets treat elevated cholesterol and triglyceride levels by activating a natural receptor that increases fat breakdown. This can help lower LDL ('bad') cholesterol, increase HDL ('good') cholesterol, and significantly reduce high triglyceride counts to mitigate pancreatitis risk. It is part of a comprehensive management plan including lifestyle adjustments.

Key Points

  • Primary Use: Fenofibrate tablets are used to treat high triglycerides and high cholesterol, typically in combination with a diet and exercise plan.

  • Mechanism: It works by activating PPAR-alpha, a natural receptor that increases the breakdown of fat and decreases the liver's production of triglycerides.

  • Pancreatitis Prevention: For patients with severely high triglycerides, fenofibrate can lower levels to reduce the risk of pancreatitis.

  • Diabetic Complications: In patients with type 2 diabetes, fenofibrate has been shown to slow the progression of diabetic retinopathy.

  • Risk of Muscle Injury: Caution is needed when combining fenofibrate with statins, as this can increase the risk of muscle damage.

  • Requires Monitoring: Liver and kidney function must be regularly monitored during fenofibrate therapy due to potential side effects.

  • Contraindications: Fenofibrate should not be used in patients with severe liver, kidney, or gallbladder disease.

In This Article

Fenofibrate is a medication from the fibrate class of drugs, prescribed to help manage unhealthy levels of cholesterol and triglycerides in the blood. By addressing these lipid abnormalities, the treatment aims to reduce the risk of certain health complications. It is important to note that fenofibrate therapy is always used in combination with lifestyle modifications, including a proper diet and regular exercise.

The Primary Uses of Fenofibrate Tablet

The FDA has approved fenofibrate for several key therapeutic uses related to dyslipidemia, which is a condition characterized by an imbalance of lipids in the blood.

Treatment of Severe Hypertriglyceridemia

One of the main uses of a fenofibrate tablet is to treat severe hypertriglyceridemia, or extremely high triglyceride levels. Markedly elevated levels of serum triglycerides (e.g., > 500 mg/dL) can lead to pancreatitis. Fenofibrate helps to rapidly lower these levels, thereby helping to prevent pancreatitis.

Management of Mixed Dyslipidemia

Fenofibrate is also indicated for the treatment of mixed dyslipidemia, a condition characterized by high levels of LDL and triglycerides, and low levels of HDL. Fenofibrate helps to improve the lipid profile by reducing triglycerides and LDL-C, while increasing HDL-C. This helps manage risk factors associated with heart disease.

Slower Progression of Diabetic Retinopathy

Beyond its lipid effects, fenofibrate has shown potential benefits in patients with type 2 diabetes. Studies, including FIELD and ACCORD-Eye, indicated that fenofibrate therapy can slow the progression of diabetic retinopathy.

Mechanism of Action and How Fenofibrate Works

Fenofibrate is converted to its active form, fenofibric acid. This active metabolite activates PPAR-α, a receptor that controls genes involved in lipid metabolism.

Activating PPAR-α leads to several changes in lipid processing:

  • Enhanced lipolysis: Increases the breakdown of triglycerides.
  • Reduced production of VLDL: Decreases the liver's production of triglycerides.
  • Modified LDL particle size: Improves LDL particle composition.
  • Increased HDL levels: Boosts production of HDL components.

Comparison with Other Lipid-Lowering Medications

Fenofibrate is a fibrate, distinct from statins. They have different mechanisms and primary effects.

Feature Fenofibrate (Fibrate) Statins (e.g., atorvastatin, simvastatin)
Primary Target Primarily lowers triglycerides and raises HDL. Primarily lowers LDL cholesterol.
Mechanism of Action Activates PPAR-α. Inhibits HMG-CoA reductase.
Cardiovascular Risk Reduction Potential benefits in certain patient subgroups. More robust evidence for reducing heart attack and stroke risk.
Combination Therapy Can increase muscle damage risk with statins. Often first-line for high LDL.

Important Considerations and Side Effects

Fenofibrate requires medical supervision. Potential side effects and contraindications include:

  • Liver Function: Monitoring is needed; severe liver injury is rare.
  • Muscle Toxicity: Risk of muscle pain; rhabdomyolysis is rare. Risk increases with statins or kidney disease.
  • Kidney Function: Can increase creatinine; monitoring is necessary, and dosage adjusted for impairment.
  • Gallbladder Disease: Increases gallstone risk; contraindicated in pre-existing gallbladder disease.
  • Contraindications: Not for severe kidney or liver disease, pre-existing gallbladder disease, or hypersensitivity.
  • Drug Interactions: Can interact with warfarin and certain immunosuppressants.

Conclusion

Fenofibrate tablets are important for managing lipid disorders, especially severe hypertriglyceridemia and mixed dyslipidemia. It lowers triglycerides, can improve cholesterol levels, and may slow diabetic retinopathy progression by activating PPAR-α. However, it requires careful monitoring for side effects and drug interactions. Patients should consult their healthcare provider and maintain lifestyle changes for best results.

For more detailed information, consult the official U.S. National Library of Medicine page on fenofibrate here: https://medlineplus.gov/druginfo/meds/a601052.html.

Frequently Asked Questions

Fenofibrate tablets are used alongside a low-fat diet to treat high cholesterol and high triglyceride levels in adults. The medication helps lower LDL ('bad') cholesterol and triglycerides while raising HDL ('good') cholesterol.

Fenofibrate is a prodrug that becomes fenofibric acid in the body. This active metabolite activates a receptor called PPAR-alpha, which increases the breakdown of triglycerides and reduces their production in the liver.

Fenofibrate and statins can be taken together, but this increases the risk of muscle damage. This combination is usually only considered when necessary, and your doctor will monitor you closely for adverse effects.

Common side effects include headache, back pain, nausea, abdominal pain, and elevated liver enzymes. More serious side effects, such as severe muscle pain or liver injury, require immediate medical attention.

Yes, studies have shown that fenofibrate therapy can slow the progression of diabetic retinopathy in patients with type 2 diabetes, offering a microvascular benefit in addition to lipid control.

Fenofibrate is contraindicated for patients with severe kidney or liver disease, pre-existing gallbladder disease, nursing mothers, or those with a known allergy to fenofibrate.

It depends on the specific brand and formulation of the tablet. Some formulations, like Fenoglide and Lipofen, should be taken with a meal to improve absorption. Others, like Tricor, can be taken with or without food.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.